Home Applications 210292 Application 210292
Type ANDA
Sponsor INDOCO REMEDIES Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FEBUXOSTAT FEBUXOSTAT TABLET;ORAL 40MG No No 002 FEBUXOSTAT FEBUXOSTAT TABLET;ORAL 80MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210292-001 FEBUXOSTAT FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 A210292-002 FEBUXOSTAT FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 76 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A210292-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A210292-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 76 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 14445-156 Febuxostat Febuxostat Indoco Remedies Limited ANDA Current 14445-157 Febuxostat Febuxostat Indoco Remedies Limited ANDA Current 27808-206 Febuxostat febuxostat Tris Pharma Inc ANDA Current 27808-206 Febuxostat febuxostat Tris Pharma Inc ANDA Current 27808-207 Febuxostat febuxostat Tris Pharma Inc ANDA Current 27808-207 Febuxostat febuxostat Tris Pharma Inc ANDA Current 71610-585 Febuxostat febuxostat Aphena Pharma Solutions - Tennessee, LLC ANDA Current